Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 31;9(1):e002934. doi: 10.1136/rmdopen-2022-002934

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

DAPSA LDA response (A) and DAPSA remission (B) with guselkumab 100 mg (every 8 weeks and every 4 weeks pooled) at week 24 and increased at week 52 across PsA phenotype clusters.* *Patients with missing data at week 52: cluster 1, n=4; cluster 2, n=5; cluster 3, n=6; cluster 4, n=1; cluster 5, n=4; cluster 6, n=4; cluster 7, n=2; cluster 8, n=6. DAPSA, disease activity index for psoriatic arthritis; LDA, low disease activity; PsA, psoriatic arthritis; PsO, psoriasis.